Aldeyra Therapeutics
ALDX
ALDX
95 hedge funds and large institutions have $147M invested in Aldeyra Therapeutics in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% less funds holding
Funds holding: 111 → 95 (-16)
14% less capital invested
Capital invested by funds: $172M → $147M (-$24.9M)
39% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 36
Holders
95
Holding in Top 10
2
Calls
$1.96M
Puts
$440K
Top Buyers
| 1 | +$3.88M | |
| 2 | +$2.96M | |
| 3 | +$2.92M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.68M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
+$2.34M |
Top Sellers
| 1 | -$8.96M | |
| 2 | -$6.43M | |
| 3 | -$2.81M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.09M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.7M |